Oncology and therapy

Keyphrases

Publications

2023

Dany Habr, Brittany Wolf Glanares, Kris Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Emine Eylem Genç, İrem Sena Saraç, Hayrunnisa Arslan, Ahmet Emre Eskazan
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial. Oncology and therapy (2023)
Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy (2023)
Dana Chase, Jessica Perhanidis, Divya Gupta, Linda Kalilani, Amanda Golembesky, Antonio González-Martín
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance. Oncology and therapy (2023)
Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Dany Habr, Brittany Wolf Glanares, Kris Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Dany Habr, Brittany Wolf Glanares, Kris Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy (2023)
Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy (2023)
Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy (2023)
Emine Eylem Genç, İrem Sena Saraç, Hayrunnisa Arslan, Ahmet Emre Eskazan
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial. Oncology and therapy (2023)
D Soldato, L Arecco, E Agostinetto, M A Franzoi, E Mariamidze, S Begijanashvili, N Brunetti, S Spinaci, C Solinas, I Vaz-Luis, A Di Meglio, Matteo Lambertini
The Future of Breast Cancer Research in the Survivorship Field. Oncology and therapy (2023)
Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay A Kharat, Carolyn C Jackson, Satish Valluri, Patricia Cost, Hilary Phelps, Rafal Slowik, Timothy Klein, Lee Smolen, Xueting Yu, Adam D Cohen
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma. Oncology and therapy (2023)
Todd J Bixby, Christine J Brittle, Patricia A Mangan, Edward A Stadtmauer, Lisa R Kallenbach
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews. Oncology and therapy (2023)
Stephen Palmer, Yi Lin, Thomas G Martin, Sundar Jagannath, Andrzej Jakubowiak, Saad Z Usmani, Nasuh Buyukkaramikli, Hilary Phelps, Rafal Slowik, Feng Pan, Satish Valluri, Lida Pacaud, Graham Jackson
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma. Oncology and therapy (2023)
Sandhya Mehta, Jipan Xie, Raluca Ionescu-Ittu, Xiaoyu Nie, Winghan J Kwong
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer. Oncology and therapy (2023)
Olga Bodriagova, Rebecca Ann Previs, Lydia Gaba, Abhishek Shankar, Laura Vidal, Kamal S Saini
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023. Oncology and therapy (2023)
Andy Garnham, Franck Bruon, Céline Berthon, Delphine Lebon, Mounika Parimi, Rosalind Polya, Kahina M Makhloufi, Marie-Hélène Dramard-Goasdoue
French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study. Oncology and therapy (2023)
Shuwen Zheng, Yumei Feng, Chan Li, Jie Zhang, Ke Xie
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Oncology and therapy (2023)
Reva K Basho, Megan-Claire Chase
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast. Oncology and therapy (2023)
Danielle E Altman, Xinke Zhang, An-Chen Fu, Alissa R Rams, Jessica A Baldasaro, Samir Ali Ahmad, Michael Schlichting, Patrick Marquis, Elena Benincasa, Camilo Moulin, Vivek Pawar
Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study. Oncology and therapy (2023)
Jessie T Yan, Yue Jin, Ernest Lo, Yilin Chen, Amy E Hanlon Newell, Ying Kong, Landon J Inge
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011-2021. Oncology and therapy (2023)
Paulo Nunes Filho, Caroline Albuquerque, Mariana Pilon Capella, Marcio Debiasi
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review. Oncology and therapy (2023)
Jay Kulsh
Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer. Oncology and therapy (2023)
Duc Thanh Le, Lap Thanh Bui, Chu Van Nguyen, Kien Hung Do, Giang Le Tran, Tu Anh Do
Neoadjuvant Doxorubicin-Paclitaxel Combined Chemotherapy in Patients with Inoperable Stage III Breast Cancer: A Retrospective Cohort Study with 10 Years of Follow-Up in Vietnam. Oncology and therapy (2023)
Stephen V Liu, Ivy B Elkins, Jill Feldman, Sarah B Goldberg
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and Oncologists. Oncology and therapy (2023)
Hamdy A Azim, Samah A Loutfy, Hatem A Azim, Nermin S Kamal, Nasra F Abdel Fattah, Mostafa H Elberry, Mohamed R Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S Shohdy, Loay Kassem
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer. Oncology and therapy (2023)
Trish Abbott, Kenrick Ng, Jenny Nobes, Paula Muehlschlegel
Small-Cell Carcinoma of the Prostate - Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece. Oncology and therapy (2023)
Kai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan, Dionisia Quiroga, Mahmoud Kassem, Michael Grimm, Abdul Miah, Craig Vargo, Michael Berger, Preeti Sudheendra, Ashley Pariser, Margaret E Gatti-Mays, Nicole Williams, Daniel Stover, Sagar Sardesai, Robert Wesolowski, Bhuvaneswari Ramaswamy, Gary Tozbikian, Patrick M Schnell, Mathew Amprayil Cherian
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and therapy (2023)
Alex Filicevas, Thomas Powles
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast. Oncology and therapy (2023)

volume 11, number 1, 2023

Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy 11 (1) (2023)
Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy 11 (1) (2023)
Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy 11 (1) (2023)
Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy 11 (1) (2023)
Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy 11 (1) (2023)
Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy 11 (1) (2023)
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy 11 (1) (2023)
Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy 11 (1) (2023)
Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy 11 (1) (2023)
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy 11 (1) (2023)
Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy 11 (1) (2023)
Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy 11 (1) (2023)
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy 11 (1) (2023)
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy 11 (1) (2023)
Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy 11 (1) (2023)
Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari
Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy 11 (1) (2023)
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy 11 (1) (2023)
Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy 11 (1) (2023)